Researchers from the University of Toronto’s Leslie Dan Faculty of Pharmacy demonstrated freeze-dried reagent and hand-powered hardware workflows designed to bring biomanufacturing and diagnostics to remote laboratories. The platform focuses on enabling decentralized production of high-value bioreagents using synthetic biology and cell-free protein synthesis to bypass constraints of traditional centralized lab setups. The work targets resource-limited settings where cold-chain infrastructure and full laboratory equipment are difficult to maintain, aiming to shorten preparation and execution timelines. For industrial biomanufacturers and toolmakers, the approach offers a tangible model for lowering adoption friction of advanced assays and protein production in non-traditional sites.